- Állatok
Ipsen Biopharmaceuticals Inc.
Pharmaceutical company providing Somatuline® Depot for neuroendocrine tumors and carcinoid syndrome.
Bemutatkozás
Ipsen Biopharmaceuticals Inc. is a pharmaceutical company focused on developing and marketing prescription medicines. The company offers Somatuline® Depot (lanreotide), an FDA-approved somatostatin analog (SSA) for adult patients. This medication is indicated to slow the growth of gastrointestinal and pancreatic neuroendocrine tumors (GEP-NETs) that have spread or cannot be removed by surgery, and to treat carcinoid syndrome to reduce the need for short-acting somatostatin medicine. The product's safety and effectiveness in children are not known. The website content is specifically intended for U.S. residents and healthcare professionals.
Szolgáltatások, tevékenységek
- Provision of Somatuline® Depot (lanreotide) injection
- Treatment for gastrointestinal and pancreatic neuroendocrine tumors (GEP-NETs)
- Treatment for carcinoid syndrome
- Patient support program for Somatuline® Depot users (IPSEN CARES®)